Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Biopatent Law: Patent Strategies and Patent Management
Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
Optics in Computing
None
Patentschutz für menschliche Stammzellen
Andreas Ruster discusses and compares the patentability of human stem cells in Europe and the United States, taking into account the legal implications of both ethical and economic aspects. The analysis culminates in a proposal to integrate patent law, ethics and economics.
Biopatent Law: Patent Strategies and Patent Management
Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
Amtsblatt
None
Unpacking EU Policy-Making towards China
This book examines different intellectual frameworks for international relations, including the bureaucratic politics model, neorealism, and institutionalism as tools for understanding the European Union’s (EU) China policy. Based on a study of three political economy-related cases, it demonstrates what approaches not just apply, but apply best in various stages of the policy cycle, why some models apply to several policy stages, and why some seem to work better than others in certain policy stages. The three cases include the EU-China solar panel dispute (2012–2018), the EU investigation into Chinese mobile telecommunications networks (2012–2014), and the EU’s response to China’s rise in Africa via the European Commission initiated EU-China-Africa trilateral cooperation initiative in 2008. Those interested in EU-China affairs can apply this innovative analytical framework to these three cases and a wide range of other issues; scholars, journalists, diplomats, and businesspeople will find this book of value.
